Now Within Reach: The Latest MEDRAD® Smart Injection System
Web version

BAYER
 
Get the Latest MEDRAD® CT Injection System
Access the Newest Technology Upgrades with Financial Flexibility
Our latest CT smart injection system is within reach, utilizing the TechCAREâ„¢ Non-Obsolescence Program, Bayer in Radiology customers can upgrade¹ with financial flexibility to the MEDRAD® Stellant FLEX CT Smart Injection System.

More than a program to keep your technology up to date, TechCARE provides world-class service with the latest hardware. In fact, TechCARE Standard helps you cost-effectively standardize to the latest CT technology while also delivering a 97% uptime guarantee.

Why wait? Choose TechCARE now, and take advantage of the benefits that come from elevating your technology and uptime. Download our brochure to learn more.
 
 
  Learn More  
 
 
1When the next generation monitor becomes available, customer may request one such enhancement during the term of the agreement to replace their existing monitor with the next generation Certegra® Workstation. When the next generation injector head becomes available, customer may request one such enhancement during the term to replace their existing injector head with a remanufactured injector head. The remanufactured injector head will only be compatible with new Bayer syringes as part of our complete injection system. Mounting options (Overhead Counterpoise System (OCS) and Pedestal) are excluded. Scan room enhancement will not be installed on OCS I (OCS I was last sold in 2004). Only available for MEDRAD® Stellant Dual CT Injection System.

Bayer, the Bayer Cross, MEDRAD Stellant, MEDRAD Stellant FLEX, MEDRAD, Stellant, Stellant FLEX and TechCARE are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries.

© 2019 Bayer. This material may not be reproduced, displayed, modified or distributed without the express prior written consent of Bayer.

Bayer HealthCare LLC, 100 Bayer Boulevard, P.O. Box 915, Whippany NJ 07981.

This message is brought to you by the Pharmaceutical Division of Bayer.

Privacy Policy | Terms of Use | Contact Us | PP-PF-RAD-US-0240-1 January 2019
 
 
                           
 
 Do not reply to this email as it was sent from an unmonitored account.
  
Unsubscribe from the Breaking News.
  
Reset your password.
  
Contact AuntMinnie.com support.
  
AuntMinnie.com Privacy Policy
  
Email sent to: .
 

AuntMinnie.com, 1350 North Kolb Road, Suite 215, Tucson, AZ 85715 USA - (520) 298-1000